Literature DB >> 24251802

1, 4-Dihydropyridines: a class of pharmacologically important molecules.

Samrat A Khedkar, Pratibha B Auti1.   

Abstract

The 1, 4-dihydropyridines (DHPs), a class of drugs possess a wide variety of biological and pharmacological actions. It represents one of the most important groups of calcium-channel modulating agents and has experienced widespread use in the treatment of cardiovascular disease which includes antihypertensive, antianginal, vasodilator and cardiac depressants activities. It also shows antibacterial, anticancer, antileishmanial, anticoagulant, anticonvulsant, antitubercular, antioxidant, antiulcer, CFTR, antimalarials, neuroprotection properties, HIV-1 protease inhibitors, antifertility activities and many more. There are many drugs available in market which contains 1, 4-dihydropyridines ring as basic scaffold. Basic motive of this review is to disclose various therapeutic applications of 1, 4-dihydropyridine derivatives reported by other researchers during their research work in 2001 to 2011.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24251802

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  8 in total

Review 1.  1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues-Model Compounds Targeting Oxidative Stress.

Authors:  Astrida Velena; Neven Zarkovic; Koraljka Gall Troselj; Egils Bisenieks; Aivars Krauze; Janis Poikans; Gunars Duburs
Journal:  Oxid Med Cell Longev       Date:  2016-01-06       Impact factor: 6.543

2.  Drugs and Scaffold That Inhibit Cytochrome P450 27A1 In Vitro and In Vivo.

Authors:  Morrie Lam; Natalia Mast; Irina A Pikuleva
Journal:  Mol Pharmacol       Date:  2017-11-30       Impact factor: 4.436

3.  Bactericidal and immunomodulatory properties of magnetic nanoparticles functionalized by 1,4-dihydropyridines.

Authors:  Katarzyna Niemirowicz-Laskowska; Katarzyna Głuszek; Ewelina Piktel; Karlis Pajuste; Bonita Durnaś; Grzegorz Król; Agnieszka Z Wilczewska; Paul A Janmey; Aiva Plotniece; Robert Bucki
Journal:  Int J Nanomedicine       Date:  2018-06-11

4.  5-Oxo-hexahydroquinoline Derivatives and Their Tetrahydroquinoline Counterparts as Multidrug Resistance Reversal Agents.

Authors:  Omolbanin Shahraki; Mehdi Khoshneviszadeh; Mojtaba Dehghani; Maryam Mohabbati; Marjan Tavakkoli; Luciano Saso; Najmeh Edraki; Omidreza Firuzi
Journal:  Molecules       Date:  2020-04-16       Impact factor: 4.411

Review 5.  The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design.

Authors:  Yong Ling; Zhi-You Hao; Dong Liang; Chun-Lei Zhang; Yan-Fei Liu; Yan Wang
Journal:  Drug Des Devel Ther       Date:  2021-10-13       Impact factor: 4.162

6.  Preparation, Antibacterial Activity, and Catalytic Application of Magnetic Graphene Oxide-Fucoidan in the Synthesis of 1,4-Dihydropyridines and Polyhydroquinolines.

Authors:  Aliakbar Nosrati; Sara Amirnejat; Shahrzad Javanshir
Journal:  ChemistryOpen       Date:  2021-12       Impact factor: 2.630

7.  Sulfonyl-bridged (copper-immobilized nickel ferrite) with activated montmorillonite, [(NiFe2O4@Cu)SO2(MMT)]: a new class of magnetically separable clay nanocomposite systems towards Hantzsch synthesis of coumarin-based 1,4-dihydropyridines.

Authors:  Behzad Zeynizadeh; Soleiman Rahmani
Journal:  RSC Adv       Date:  2019-03-11       Impact factor: 3.361

8.  Comparison between 1,2-Dihydropyridine and 1,4-Dihydropyridine on Hydride-Donating Ability and Activity.

Authors:  Jin-Ye Zhang; Xiao-Qing Zhu
Journal:  Molecules       Date:  2022-08-24       Impact factor: 4.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.